Knowledge Distillery

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network

Seroprevalence of SARS-CoV-2 in Parkinson’s disease patients: a case-control study

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

COVID-19 outcomes in patients with neurodegenerative disorders are not well understood, and the authors hypothesize there may be increased morbidity…

In this retrospective, multicenter cohort study, the authors compared patients with RRMS on EID (defined as ≥4-week delay of dose interval) with a…

In this study, the authors analyze the characteristics, evaluation, treatment, and in-hospital outcomes of patients presenting with acute ischemic…

In this article the authors aimed to analyse the range and prevalence of neurological and psychiatric complications associated with paediatric…

In this study the authors identified breakthrough infections by performing extensive evaluations of health care workers who were symptomatic…

In this article the authors detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω in 13.6% of 3,595…

This cohort study evaluates the COVID-19-related case fatality rate (CFR) of patients with pre-existing neurological diseases.

In this study the authors retrospectively analyzed motor symptoms of longitudinally followed PD patients (n = 264) and compared motor disease…

The aim of the present study was to administer the COMPASS-31 questionnaire to a sample of post-COVID patients with and without neurological…